UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Outcome of Acute Promyelocytic Leukemia (APL) with Very High WBC Counts Treated with ATRA and Chemotherapy (CT): The European Group Experience

Blood, 2007-11, Vol.110 (11), p.1845-1845

2007

Volltextzugriff (PDF)

Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients

Journal of antimicrobial chemotherapy, 1998-06, Vol.41 Suppl D (suppl 4), p.57-64

1998

Volltextzugriff (PDF)

Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission : an analysis of the EORTC-GIMEMA AML 8A Trial

Bone marrow transplantation (Basingstoke), 1996-06, Vol.17 (6), p.993-1002

1996

Volltextzugriff (PDF)

Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients

Supportive care in cancer, 1999-03, Vol.7 (2), p.89-94

1999

Volltextzugriff (PDF)

Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL): A Comparison between French -Belgian-Swiss and Spanish Results

Blood, 2005-11, Vol.106 (11), p.544-544

2005

Volltextzugriff (PDF)

Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials)

Blood, 2005-11, Vol.106 (11), p.890-890

2005

Volltextzugriff (PDF)

A case of disseminated aspergillosis with thyroid involvement

European journal of clinical microbiology & infectious diseases, 2001-05, Vol.20 (5), p.358-359

2001

Volltextzugriff (PDF)

Treatment of hairy cell leukaemia (HCL) with 2‐chlorodeoxyadenosine (2‐CdA): identification of parameters predictive of adverse effects

British journal of haematology, 1997-10, Vol.99 (1), p.165-167

1997

Volltextzugriff (PDF)

Le rituximab est-il une alternative à la splénectomie chez les adultes atteints d'un purpura thrombopénique immunologique chronique ? Résultats d'une étude prospective multicentrique de phase 2

La revue de medecine interne, 2006-12, Vol.27, p.S297-S298

2006

Volltextzugriff (PDF)

Is ARAC Required in the Treatment of Newly Diagnosed APL? Results of a Randomized Trial (APL 2000)

Blood, 2004-11, Vol.104 (11), p.391-391

2004

Volltextzugriff (PDF)

Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemia

Leukemia research, 2000-11, Vol.24 (11), p.957-963

2000

Volltextzugriff (PDF)

Relapse after autologous hematopoietic stem cell transplantation in acute myeloid leukemia, a single center experience over 13 years

American journal of hematology, 2000-07, Vol.64 (3), p.232-233

2000

Volltextzugriff (PDF)

Impact thérapeutique des bactériémies à streptocoques et à entérocoques chez des malades d'hématologie

Pathologie biologie (Paris), 2002-04, Vol.50 (3), p.169-177

2002

Volltextzugriff (PDF)

Neutropenic infections : a review of the french Febrile Aplasia Study Group trials in 608 febrile neutropenic patients: Infection in the neutropenic patient

Journal of antimicrobial chemotherapy, 1998, Vol.41, p.57-64

1998

Volltextzugriff (PDF)

Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia

Leukemia, 2000-06, Vol.14 (6), p.1006

2000

Volltextzugriff (PDF)

Treatment of relapsing acute promyelocytic leukemia by all-transretinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation

Leukemia, 2000-06, Vol.14 (6)

2000

Volltextzugriff (PDF)

Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients

Pathologie biologie (Paris), 2002-04, Vol.50 (3), p.169

2002

Volltextzugriff (PDF)

Modulation de la résistance multiple aux chimiothérapies

Hématologie (Montrouge), 1997, Vol.3 (2), p.62-63

1997

Volltextzugriff (PDF)

Evaluation of Carboplatin as a Single Agent in Highly Refractory Acute Myeloid Leukemia

Leukemia & lymphoma, 1994, Vol.15 (3-4), p.311-315

1994

Volltextzugriff (PDF)

Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups

Bone marrow transplantation (Basingstoke), 1996-06, Vol.17 (6), p.993-1001

1996

Volltextzugriff (PDF)

Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles

La Presse médicale (1983), 1995-02, Vol.24 (8), p.397

1995

Volltextzugriff (PDF)

Piperacillin/tazobactam + amikacin versus ceftazidime + amikacin in neutropenic patients with fever: An open multicentric trial

La Presse médicale (1983), 1995-01, Vol.24 (8), p.397-401

1995

Volltextzugriff (PDF)

Association pipéracilline/tazobactam+amikacine versus ceftazidime+amikacine chez les patients neutropéniques et fébriles : étude multicentrique ouverte

La Presse médicale (1983), 1995, Vol.24 (8), p.397-401

1995

Volltextzugriff (PDF)

Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies

Comptes rendus de l'Académie des sciences, Série III, Sciences de la vie, 1992, Vol.315 (13), p.545

1992

Volltextzugriff (PDF)

Brief communication: Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes

Leukemia research, 1901-01, Vol.33 (4), p.547-550

1901

Volltextzugriff (PDF)

26 – 49 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(47)
Tagungsberichte
(2)

Sprache

Englisch
(39)
Französisch
(10)

Erscheinungsjahr

n.n

Thema

Humans
(31)
Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Female
(26)
Male
(25)
Middle Aged
(25)
Adult
(24)
Biological And Medical Sciences
(23)
Medical Sciences
(22)
Aged
(20)
Hematology
(19)
Oncology
(15)
Hematologic And Hematopoietic Diseases
(11)
Pharmacology. Drug Treatments
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Chemotherapy
(9)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(9)
Treatment Outcome
(9)
Adolescent
(7)
Leukemia
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Leukemia
(9)
Blood
(5)
Leukemia Research
(4)
Haematologica
(3)
Bone Marrow Transplantation
(2)
Encéphale
(2)
Journal Of Antimicrobial Chemotherapy
(2)
La Presse Médicale
(2)
Leukemia & Lymphoma
(2)
Pathologie Biologie
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outcome of Acute Promyelocytic Leukemia (APL) with Very High WBC Counts Treated with ATRA and Chemotherapy (CT): The European Group Experience

Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients

Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission : an analysis of the EORTC-GIMEMA AML 8A Trial

Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients

Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL): A Comparison between French -Belgian-Swiss and Spanish Results

Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials)

A case of disseminated aspergillosis with thyroid involvement

Treatment of hairy cell leukaemia (HCL) with 2‐chlorodeoxyadenosine (2‐CdA): identification of parameters predictive of adverse effects

Le rituximab est-il une alternative à la splénectomie chez les adultes atteints d'un purpura thrombopénique immunologique chronique ? Résultats d'une étude prospective multicentrique de phase 2

Is ARAC Required in the Treatment of Newly Diagnosed APL? Results of a Randomized Trial (APL 2000)

Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemia

Relapse after autologous hematopoietic stem cell transplantation in acute myeloid leukemia, a single center experience over 13 years

Impact thérapeutique des bactériémies à streptocoques et à entérocoques chez des malades d'hématologie

Neutropenic infections : a review of the french Febrile Aplasia Study Group trials in 608 febrile neutropenic patients: Infection in the neutropenic patient

Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia

Treatment of relapsing acute promyelocytic leukemia by all-transretinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation

Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients

Modulation de la résistance multiple aux chimiothérapies

Evaluation of Carboplatin as a Single Agent in Highly Refractory Acute Myeloid Leukemia

Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles

Piperacillin/tazobactam + amikacin versus ceftazidime + amikacin in neutropenic patients with fever: An open multicentric trial

Association pipéracilline/tazobactam+amikacine versus ceftazidime+amikacine chez les patients neutropéniques et fébriles : étude multicentrique ouverte

Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies

Brief communication: Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes

Suchergebnisse filtern